FDA Drug Application (011284) for MEPROSPAN by MEDPOINTE PHARM HLC

Back to FDA Applications sponsored by MEDPOINTE PHARM HLC

Application Number011284
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage200MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameMEPROSPAN
Active IngredientMEPROBAMATE

Active IngredientCount
List of drugs with Active Ingredient MEPROBAMATE18


Back to FDA Applications sponsored by MEDPOINTE PHARM HLC